XML 155 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Cover - USD ($)
 12 Months Ended
Dec. 31, 2023
Feb. 14, 2024
Jun. 30, 2023
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2023    
Current Fiscal Year End Date --12-31    
Document Fiscal Year Focus 2023    
Document Fiscal Period Focus FY    
Document Transition Report false    
Entity File Number 001-39567    
Entity Registrant Name C4 Therapeutics, Inc.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 47-5617627    
Entity Address, Address Line One 490 Arsenal Way    
Entity Address, Address Line Two Suite 120    
Entity Address, City or Town Watertown    
Entity Address, State or Province MA    
Entity Address, Postal Zip Code 02472    
City Area Code 617    
Local Phone Number 231-0700    
Title of 12(b) Security Common Stock, $0.0001 par value per share    
Trading Symbol CCCC    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Public Float     $ 129,573,953
Entity Common Stock, Shares Outstanding   68,600,669  
Amendment Flag false    
Entity Central Index Key 0001662579    
Documents Incorporated by Reference
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the registrant’s definitive proxy statement for its 2023 Annual Meeting of Stockholders to be filed pursuant to Regulation 14A within 120 days of the end of the registrant’s fiscal year ended December 31, 2023 are incorporated by reference into Part III of this Annual Report on Form 10-K to the extent stated herein.